A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe

UnknownOBSERVATIONAL
Enrollment

407

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

October 31, 2019

Study Completion Date

March 31, 2020

Conditions
Autosomal Dominant Polycystic Kidney Disease
Trial Locations (26)

Unknown

AKH Wien, Vienna

LKH Villach, Villach

UCL Brussels, Brussels

UZ Brussels, Brussels

UZ Leuven/Gasthuisberg KUL, Leuven

CHU Liège - Domaine Universitaire du Sart Tilman, Liège

Clinique La Louviere, Lille

CHU Nimes - Hôpital CAREMEAU, Nîmes

Hopital Tenon, Paris

Necker Hospital, Paris

CHU TOURS - Hôpital Bretonneau, Tours

Charite Berlin, Berlin

Universitätsmedizin Göttingen, Göttingen

University Medical Center Schleswig-Holstein, Lübeck

Fundación Puigvert, Barcelona

Hospital Clinic, Barcelona

Hospital Vall d'Hebron, Barcelona

Hospital Universitario de Getafe, Getafe

University Hospital of Geneve, Geneva

University Hospital of Zurich, Zurich

Edinburgh Royal Infirmary, Edinburgh

Queen Elizabeth University Hospital, Glasgow

Aintree University Hospital, Liverpool

Royal Free Hospital, London

Royal London Hospital, London

Freeman Hospital, Newcastle

All Listed Sponsors
lead

Otsuka Pharmaceutical Europe Ltd

INDUSTRY

NCT02848521 - A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe | Biotech Hunter | Biotech Hunter